cifenline has been researched along with Left Ventricular Dysfunction in 4 studies
| Excerpt | Relevance | Reference |
|---|
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamada, M | 2 |
| Ikeda, S | 2 |
| Shigematsu, Y | 2 |
| Kajimoto, K | 1 |
| Imai, T | 1 |
| Minami, Y | 1 |
| Kasanuki, H | 1 |
| Izawa, A | 1 |
| Kinoshita, O | 1 |
| Shiba, Y | 1 |
| Takahashi, W | 1 |
| Uchikawa, S | 1 |
| Imamura, H | 1 |
| Owa, M | 1 |
| Kubo, K | 1 |
| Aono, J | 1 |
| Watanabe, K | 1 |
| Inaba, S | 1 |
| Suzuki, J | 1 |
| Ohtsuka, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluating the Effect of Spironolactone on Hypertrophic Cardiomyopathy-- a Multicenter Randomized Control Trial[NCT02948998] | Phase 4 | 260 participants (Anticipated) | Interventional | 2018-05-14 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for cifenline and Left Ventricular Dysfunction
| Article | Year |
|---|---|
Advances in medical treatment of hypertrophic cardiomyopathy.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Anti-Arrhythmia Agents; Calcium Channel Blocke | 2014 |
1 trial available for cifenline and Left Ventricular Dysfunction
| Article | Year |
|---|---|
Effect of intravenous administration of cibenzoline on left ventricular diastolic pressures in patients with hypertrophic cardiomyopathy: its relationship to transmitral Doppler flow profiles.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Natriuretic Factor; Blood Pressure; Cardiomyopathy, Hypertrophi | 2007 |
2 other studies available for cifenline and Left Ventricular Dysfunction
| Article | Year |
|---|---|
Comparison of acute reduction in left ventricular outflow tract pressure gradient in obstructive hypertrophic cardiomyopathy by disopyramide versus pilsicainide versus cibenzoline.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiomyopathy, Hypertrophic; Disopyramide; Echocardiography, D | 2010 |
Percutaneous cardiopulmonary support aids resuscitation from sustained ventricular tachycardia.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Assisted Circulation; Humans; Imidazoles; Male; Resuscitat | 2003 |